Summary

Summary

Contract Unique IdentifierDO1.SLCNTR.444205 
Contract referenceInst. Nac. de Cancer-2020-00395 
Contract description:MEDICAMENTOS ONCOLÓGICOS 
Goods 
Contract Start:
22/05/2020 09:00:00 ((UTC-04:00) Georgetown, La Paz, Manaus, San Juan)
 
Contract End:
07/09/2020 09:00:00 ((UTC-04:00) Georgetown, La Paz, Manaus, San Juan)
 
Legally Binding?
 
Contract StateAccepted 

Contracting Company Identification

Contracting Company Identification


Supplier Company Identification

Supplier Company Identification



Object Info

Object Info

DGCP-08-ProcesosExcepcion 
Inst. Nac. de Cancer-CCC-PEEX-2020-0018 
MEDICAMENTOS ONCOLÓGICOS  
MEDICAMENTOS ONCOLÓGICOS  
LOGISTICA 
DOCTORES MALLEN GUERRA COTIZACION NO. 004308_EXT_C 
GoodsDominicana 
31,971,874 Dominican Pesos 

Financial & Delivery Conditions

Financial & Delivery Conditions

Delivery optionsTransporte incluido 
Contract Start Date
21/05/2020 10:00:00 ((UTC-04:00) Georgetown, La Paz, Manaus, San Juan)
 
Contract End Date
03/08/2020 09:00:00 ((UTC-04:00) Georgetown, La Paz, Manaus, San Juan)
 
nstituto Nacional del Cáncer Rosa Emilia Sánchez Pérez de Tavares Av. Correa y Cidrón, Esq. Rafael A. Sánchez Ravelo, Zona Universitaria DO 

Payment Conditions

Payment Conditions

Payment Method 
Invoice Payment Deadline60 days 

Contract Comments

Contract Comments


 
 
 1 
DO1.PCCNTR.873943 ContractData Container
 1.1  
-
    
Total sin descuentosValor del descuentoTotal ITBISTotal Otros ImpuestosSubtotalTotal
31,107,874.000.000.000.0031,976,374.0031,971,874.00
    
ReferenciaCódigo UNSPSCCuenta presupuestariaDescripciónCantidadUnidadPrecio unitario estimadoPrecio unitarioImporte moneda orig. s/ITBIS% Desc.Descuento moneda originalMonto Gravado (Obras)% ITBISITBIS Moneda Original% Otros ImpuestosOtros impuestos moneda originalPrecio total estimadoValor del precio de respuesta
    
2
51111713 - Alemtuzumab
2.3.4.1.01BEVACIZUMAB 100 MG INY ( AVASTIN)90UD24,80024,8002,232,000.000.000.000.002,232,000.002,232,000.00
    
3
51111713 - Alemtuzumab
2.3.4.1.01BEVACIZUMAB 400 MG INY ( AVASTIN) 76UD97,82797,8277,434,852.000.000.000.007,434,852.007,434,852.00
    
4
51111616 - Capecitabina
2.3.4.1.01CAPECITABINA 500 MG (XELODA) 18,000UD174173.753,127,500.000.000.000.003,132,000.003,127,500.00
    
5
51111618 - Metotrexato de(...)
2.3.4.1.01PERTUZUMAB 420 MG ( PERJETA )10UD210,090210,0902,100,900.000.000.000.002,100,900.002,100,900.00
    
6
51111716 - Rituximab
2.3.4.1.01RITUXIMAB 1,400MG/ 11.7 ML INY (MABTHERA)46UD78,00078,0003,588,000.000.000.000.003,588,000.003,588,000.00
    
7
51111716 - Rituximab
2.3.4.1.01RITUXIMAB 100 MG / 10 ML (MABTHERA)128UD13,50013,500864,000.000.000.000.001,728,000.001,728,000.00
    
8
51111716 - Rituximab
2.3.4.1.01RITUXIMAB 500MG /INY (MABTHERA)30UD67,00067,0002,010,000.000.000.000.002,010,000.002,010,000.00
    
9
51111717 - Trastuzumab
2.3.4.1.01TRASTUZUMAB 600 MG / 5ML (HECEPTIN)106UD91,98791,9879,750,622.000.000.000.009,750,622.009,750,622.00
 
Contract Document Template

Contract Document Template

DescriptionFile Name
Download
Download
Download
Download

Budget Settings

Budget Settings

Investment
Own resources
34,410,424.00 DOP
 DOP
AccountValueAnnual Availability
2.3.4.1.0134,410,424.00  DOP----View
Payment Calendar
IDDescriptionValueMonthYear
No items found...
Certificate of Appropriation
YearCertificate CodeCertificate VersionCertificate ValueCertificate StateCertificate Link
20201134,410,424.00  DOP